Sanofi in talks to sell 50% stake in consumer health business

Sanofi is entering negotiations with Clayton, Dublier & Rice regarding the potential sale of a 50% controlling stake in its consumer health business, Opella. 

Advertisement

Sanofi said any further updates on the potential separation from Opella will be provided when a decision is made, according to a press release from the agency. 

Headquartered in France, Opella employs more than over 11,000 people and operates in 100 countries and ranks as the world’s third-largest company in the over-the-counter vitamins, minerals and supplements market.

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

The Performance Gap Your Pharmacy Training Metrics Can’t See

Monday, August 10
12:00 PM - 1:00 PM CDT

Presenters: Michael Alexander, AudirieDr. Tina Moen, PharmD, Colibri Healthcare

Advertisement

Next Up in Pharmacy

  • Morgantown, W.Va.-based WVU Medicine has opened the WVUH Community Pharmacy, expanding access to pharmacy services for residents, patients, students and…

  • Active U.S. drug shortages increased to 227 in the second quarter of 2026, marking the third consecutive quarterly increase, according…

Advertisement

Comments are closed.